New weight loss drugs including Mounjaro, Ozempic, Wegovy and others have been making huge headlines lately. These medications originally intended as type 2 diabetes treatments have been associated with side effects that include losing bodyweight, and the FDA in the United States, Health Canada in Canada, and other national regulating bodies have been rapidly reviewing them for use as obesity treatments too.